4//SEC Filing
Stilley William B. III 4
Accession 0001213900-21-062729
CIK 0001513525other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:25 AM ET
Size
7.5 KB
Accession
0001213900-21-062729
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2021-11-29$2.59/sh+10,000$25,892→ 927,046 total - Purchase
Common Stock
2021-11-30$2.75/sh+10,600$29,179→ 937,646 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These 10,000 shares of common stock were purchased in multiple transactions at prices ranging from $2.54 to $2.60, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4
- [F2]The price reported in Column 4 is a weighted average price. These 10,600 shares of common stock were purchased in multiple transactions at prices ranging from $2.5999 to $2.83, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718069
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 9:25 AM ET
- Size
- 7.5 KB